# Abridge

> AI medical conversation platform that turns clinician-patient dialogue into structured notes.

## Why it is interesting

Abridge competes in the hot clinical documentation category with strong hospital distribution. Together with Ambience, it maps the “AI scribe” war.

## Profile

- **Stage:** growth
- **Status:** private
- **Industries:** healthtech, ai-ml
- **Coverage:** full
- **Last updated:** 2026-07-24

## Key facts

- Series C (Feb 2024): $150M co-led by Lightspeed and Redpoint with Spark, USV, Bessemer (Abridge press release)
- Series E (Jun 2025): $300M led by a16z with Khosla Ventures participation (STAT News)

## Investors in our directory

- https://venturecapitaltracker.com/fund/andreessen-horowitz
- https://venturecapitaltracker.com/fund/lightspeed-venture-partners-nyc
- https://venturecapitaltracker.com/fund/redpoint-ventures
- https://venturecapitaltracker.com/fund/spark-capital
- https://venturecapitaltracker.com/fund/union-square-ventures
- https://venturecapitaltracker.com/fund/bessemer-venture-partners
- https://venturecapitaltracker.com/fund/khosla-ventures

---
Source: https://venturecapitaltracker.com/startup/abridge